New J&J anti-depressant related to 'Special K' party drug
By Ransdell Pierson NEW BRUNSWICK, New Jersey (Reuters) - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017...
Read More »By Ransdell Pierson NEW BRUNSWICK, New Jersey (Reuters) - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017...
Read More »DUBAI (Reuters) - Saudi Arabia has announced another death from the SARS-like novel coronavirus (nCoV) in its central al-Qassim regi...
Read More »HELSINKI/LONDON (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not...
Read More »
By Julie Steenhuysen CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she...
Read More »By Corrie MacLaggan AUSTIN, Texas (Reuters) - Texas came a step closer to requiring some applicants for unemployment benefits to fir...
Read More »By Jessica Dye NEW YORK (Reuters) - A U.S. Senate committee on Wednesday unanimously approved legislation that would increase federa...
Read More »By Verna Gates BIRMINGHAM, Alabama (Reuters) - U.S. and state health authorities are investigating an unidentified respiratory illne...
Read More »
By Toni Clarke WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug moved a step closer to U.S. approval on Wednesday afte...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - In a new study, people with high blood pressure who could communicate with their phar...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Daily vitamin C supplements don't lower uric acid as much as drugs used to treat hig...
Read More »